Seratrodast structure
Seratrodast
Pale Orange SolidSeratrodast, a novel benzoquinone derivative, is the first thromboxane A2(TxA2) receptor antagonist to reach the market. It is orally active for the treatment of bronchospastic disorders such as asthma. TxA2, a metabolite of the arachidonate cascade, is involved in several cardiovascular and respiratory diseases through its potent biological effects on platelet aggregation and constriction of vascular and respiratory smooth muscles.
Find 3 Related Holders
Nanjing Pharmaceutical FACTORY Co., Ltd.
China
China
API Registration Country
API Active
-
Founded in:
1991-07-11 -
Country:
China -
Address:
No. 26, Xingang Avenue, Nanjing Economic and Technological Development Zone -
Tax NO.:
91320192134908655F -
Registered Funds:
200.8 million yuan -
Website:
-
Email:
Changzhou Watson Pharmaceuticals Co., Ltd.
China
China
API Registration Country
API Active
-
Founded in:
1996-03-25 -
Country:
China -
Address:
No. 98, Hehai Road, Xinbei District, Changzhou -
Tax NO.:
91320411608126453T -
Registered Funds:
$18 million -
Website:
-
Email:
Shandong Lukang Pharmaceutical Co., Ltd.
China
China
API Registration Country
API Active
-
Founded in:
1993-02-15 -
Country:
China -
Address:
No. 88, Deyuan Road, Jining High-tech Zone, Shandong Province -
Tax NO.:
913700001659297311 -
Registered Funds:
880.229735 yuan -
Website:
-
Email:
Recommended Suppliers of Seratrodast
-
Amitychem
CN1 YR
Contact Supplier -
GIHI CHEMICALS CO.,LIMITED
CN1 YR
Contact Supplier -
XIAMEN EQUATION CHEMICAL CO.,LTD
CN1 YR
Contact Supplier -
Hangzhou Dawn Ray Pharmaceutical Co.,Ltd
CN1 YR
Contact Supplier -
HANGZHOU LEAP CHEM CO., LTD.
CN1 YR
Contact Supplier